TCG Crossover Management »

Forte Biosciences shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $20M 920k 21.25

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Comm (ABVX)
Tango Therapeutics Comm (TNGX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Immunovant Comm (IMVT)
Spyre Therapeutics Comm (SYRE)
Dianthus Therapeutics Comm (DNTH)
Mirum Pharmaceuticals Comm (MIRM)
Zai Lab Ltd- Adrs (ZLAB)
Amylyx Pharmaceuticals Comm (AMLX)
Monte Rosa Therapeutics Comm (GLUE)
Biocryst Pharmaceuticals Comm (BCRX)
Vor Biopharma Comm (VOR)
Tyra Biosciences Comm (TYRA)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding Forte Biosciences

Federated Investors
OrbiMed Advisors
Fred Alger Management
Jupiter Topco
BlackRock
Henderson Group
Affinity Asset Advisors
MPM Oncology Impact Management
TCG Crossover Management
Vanguard Capital Management
Woodline Partners
Adage Capital Partners GP
Integral Health Asset Management
Millennium Management
Citadel Advisors

View all funds holding Forte Biosciences